Your browser doesn't support javascript.
loading
Functional enhancement of mesothelin-targeted TRuC-T cells by a PD1-CD28 chimeric switch receptor.
McCarthy, Derrick; Lofgren, Michael; Watt, Amy; Horton, Holly; Kieffer-Kwon, Philippe; Ding, Jian; Kobold, Sebastian; Baeuerle, Patrick A; Hofmeister, Robert; Gutierrez, Dario A; Tighe, Robert.
Afiliación
  • McCarthy D; TCR2 Therapeutics, Inc., 100 Binney Street, Suite 710, Cambridge, MA, 02142, USA.
  • Lofgren M; Adaptimmune, Philadelphia, PA, USA.
  • Watt A; Adaptimmune, Philadelphia, PA, USA.
  • Horton H; TCR2 Therapeutics, Inc., 100 Binney Street, Suite 710, Cambridge, MA, 02142, USA.
  • Kieffer-Kwon P; TCR2 Therapeutics, Inc., 100 Binney Street, Suite 710, Cambridge, MA, 02142, USA.
  • Ding J; TCR2 Therapeutics, Inc., 100 Binney Street, Suite 710, Cambridge, MA, 02142, USA.
  • Kobold S; Center of Integrated Protein Science Munich (CIPS­M) and Division of Clinical Pharmacology, Department of Medicine IV, Member of the German Center for Lung Research (DZL), University Hospital, Ludwig-Maximilians-Universität, Munich, Germany.
  • Baeuerle PA; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
  • Hofmeister R; TCR2 Therapeutics, Inc., 100 Binney Street, Suite 710, Cambridge, MA, 02142, USA.
  • Gutierrez DA; Institute of Immunology, Ludwig-Maximilians-Universität, Munich, Germany.
  • Tighe R; TCR2 Therapeutics, Inc., 100 Binney Street, Suite 710, Cambridge, MA, 02142, USA.
Cancer Immunol Immunother ; 72(12): 4195-4207, 2023 Dec.
Article en En | MEDLINE | ID: mdl-37848682

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antígenos CD28 / Mesotelioma Límite: Humans Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antígenos CD28 / Mesotelioma Límite: Humans Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
...